Covered recipient · General Payments record
OLGA VARNACHEVA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2021–2022
$876.24
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $244.91 | 10 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $105.72 | 3 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $25.02 | 1 |
| Abbott Laboratories | $24.76 | 1 |
| ABBVIE INC. | $24.01 | 1 |
| Acerta Pharma LLC | $18.70 | 1 |
| Almatica Pharma Inc. | $17.87 | 1 |
| Lilly USA, LLC | $15.04 | 1 |
| GlaxoSmithKline, LLC. | $13.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.76 | 03/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920116283 | CMS |
| ABBVIE INC. | $24.01 | 06/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892348095 | CMS |
| Almatica Pharma LLC | $17.87 | 01/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 896665913 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.70 | 02/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914917123 | CMS |
| Biohaven Pharmaceutical Holding Company Ltd. | $25.02 | 06/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923963265 | CMS |
| GlaxoSmithKline, LLC. | $13.79 | 02/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944575891 | CMS |
| Lilly USA, LLC | $15.04 | 03/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918654279 | CMS |
| Novo Nordisk Inc | $13.30 | 02/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899502745 | CMS |
| Novo Nordisk Inc | $16.83 | 05/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899023953 | CMS |
| Novo Nordisk Inc | $75.59 | 05/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898878427 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022
- Source files
- Dataset page · Bulk file · PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.